Cargando…
Adaptive, platform trials assessing therapies for hospitalized COVID-19 patients: Informed consent forms omitted a few important elements of information
BACKGROUND: The information provided to participants of adaptive platform trials assessing therapies for COVID-19 inpatients is unknown. We aim to evaluate it by reviewing participant information sheets/informed consent forms (PIS/ICFs). METHODS: We searched the Cochrane COVID-19 Study Register and...
Autores principales: | Dal-Ré, Rafael, Voo, Teck Chuan, Holm, Søren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173897/ https://www.ncbi.nlm.nih.gov/pubmed/37166268 http://dx.doi.org/10.7189/jogh.13.06019 |
Ejemplares similares
-
Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable
por: Dal-Ré, Rafael, et al.
Publicado: (2022) -
How WHO Solidarity Plus trial participants in countries on four continents are informed in writing
por: Dal-Ré, Rafael, et al.
Publicado: (2023) -
The approach to informed consent in acute care research
por: Dal-Ré, Rafael, et al.
Publicado: (2022) -
Waivers of informed consent in research with competent participants and the Declaration of Helsinki
por: Dal-Ré, Rafael
Publicado: (2023) -
Pharmaceutical information systems and possible implementations of informed consent - developing an heuristic
por: Ploug, Thomas, et al.
Publicado: (2012)